Mette Heringa (M Heringa)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 11

Top Topics

Clinical Decision Support

St Elevation Myocardial Infarction

Fluorescent Probe

Top Venues

Pharmacoepidemiology and drug safety

The British journal of general practice : the journal of the Royal College of General Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

W E Ellen van Loon, Maarten Lambert, Mette Heringa, M Marcel Bouvy, Katka Taxis
Community pharmacists' attitudes towards checking prescriptions: a cross-sectional survey. The International journal of pharmacy practice (2024)
E A W Jansen-Groot Koerkamp, Y M Weesie, Mette Heringa, Karin Hek, Jeanet W Blom, Mattijs Everard Numans, Liset van Dijk, M Marcel Bouvy
General practitioners' and community pharmacists' beliefs and practices on opioids for non-malignant pain. European journal of pain (London, England) (2024)
Amar D Levens, Melina C den Haan, Johan Wouter Jukema, Mette Heringa, Wilbert B van den Hout, Dirk Jan A R Moes, Jesse Joachim Swen
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors. Genes 14 (3) (2023)
Amar D Levens, Melina C den Haan, Johan Wouter Jukema, Mette Heringa, Wilbert B van den Hout, Dirk Jan A R Moes, Jesse Joachim Swen
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors. Genes 14 (3) (2023)
Elsemiek A W Jansen-Groot Koerkamp, Loes de Kleijn, Romina Fakhry, Alessandro Chiarotto, Mette Heringa, Hanneke J B M Rijkels-Otters, Jeanet W Blom, Mattijs Everard Numans, Bart W Koes, M Marcel Bouvy
Pragmatic Delphi study aimed at determining practical components for a tool designed to assist Dutch primary care-givers in opioid deprescribing for non-cancer pain. Family practice (2023)
Amar D Levens, Melina C den Haan, Johan Wouter Jukema, Mette Heringa, Wilbert B van den Hout, Dirk Jan A R Moes, Jesse Joachim Swen
Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors. Genes 14 (3) (2023)
Lieke Maria Koggel, Marten Alexander Lantinga, Frederike Leonie Büchner, Joost Paulus Hubertus Drenth, Jacqueline Sarah Frankema, Edwin Johannes Heeregrave, Mette Heringa, Mattijs Everard Numans, Peter Derk Siersema
Predictors for inappropriate proton pump inhibitor use: observational study in primary care. The British journal of general practice : the journal of the Royal College of General Practitioners 72 (725) (2022)
S D Sander Borgsteede, Mette Heringa
Nature and frequency of dosing instructions on prescription labels in primary care. Pharmacoepidemiology and drug safety 28 (8) (2019)
Mette Heringa, Annemieke Floor-Schreudering, Hans Wouters, Peter A G M De Smet, Marcel L Bouvy
Preferences of Patients and Pharmacists with Regard to the Management of Drug-Drug Interactions: A Choice-Based Conjoint Analysis. Drug safety 41 (2) (2018)
Mette Heringa, Annemieke Floor-Schreudering, Peter A G M De Smet, Marcel L Bouvy
Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice. Drugs & aging 34 (11) (2018)
Mette Heringa, Annemieke Floor-Schreudering, P Chris Tromp, Peter A G M de Smet, Marcel L Bouvy
Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy. Pharmacoepidemiology and drug safety 25 (1) (2015)